IL13 and neoplasm: Interestingly, type 2 cytokines promote tumour metastasis and contribute to chemoresistance, and miR‐126 has been shown to promote tumour angiogenesis via a TH2‐dependent IL‐13 release mechanism, in a model of breast tumour metastasis.174